Stocklytics Platform
Inogen
INGN52
$7.45arrow_drop_down5.39%-$0.42
INGN52

$7.45

arrow_drop_down5.39%
Key Stats
Open$7.83
Prev. Close$7.88
EPS-1.52
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
Market Cap$176.70M
PE Ratio-
LOWHIGH
Day Range7.40
7.88
52 Week Range4.13
13.33
no data available for fundamentals

There's no data available for fundamentals

Stock Analysis

Stock Performance

INGN-
US Tech-
US Market-

Inogen (INGN) Statistics

Inogen Inc, also known as INGN, is a publicly traded company that specializes in the development and manufacture of portable oxygen concentrators. The company was founded in 2001 and is headquartered in Goleta, California. As of 2021, Inogen Inc has a market capitalization of $2.5 billion and operates in the healthcare sector.
When it comes to valuation metrics, Inogen Inc has a price-to-earnings ratio (P/E) of 43.7, indicating that investors are willing to pay a premium for the company's earnings. The price-to-sales ratio (P/S) stands at 3.5, reflecting the company's revenue per share. In terms of fundamentals, Inogen Inc has a return on equity (ROE) of 13.5%, indicating the company's ability to generate profits with shareholders' investments. Additionally, the company has a current ratio of 6.2, highlighting its strong liquidity position.
add Inogen  to watchlist

Keep an eye on Inogen

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is the EBITDA of Inogen (INGN) stock?

The EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) of Inogen (INGN) is -$21.51M. EBITDA is a widely used earnings metric to assess a company's operational efficiency and profitability before the impact of non-operating decisions such as financing, accounting, and tax environments.
help

How has Inogen (INGN) stock's performance compared to its sector and the market over the past year?

Over the past year, Inogen (INGN) has experienced a price change of . Compared to the Healthcare sector, which saw a change of 18.46%, Inogen has underperformed compared to its sector, indicating its relative standing within the Healthcare sector. Against the broader market's change of 31.78%, it has fallen short of the market average. This comparison highlights Inogen 's performance relative to both its sector and the overall market over the last year.
help

What is the PE ratio of Inogen (INGN) stock?

The PE ratio for Inogen (INGN) is currently not available. This could be due to a variety of factors such as the company not having positive earnings at the moment or recent updates not being reflected.
help

What is the EPS of Inogen (INGN) stock?

The Earnings Per Share (EPS) for Inogen (INGN), calculated on a diluted basis, is -$1.52. EPS is a key indicator of a company's profitability, showing the portion of a company's profit allocated to each outstanding share of common stock.
help

What is the operating margin of Inogen (INGN) stock?

The operating margin for Inogen (INGN) is -14.22%. This metric represents the percentage of revenue that remains after paying for variable production costs, indicating the efficiency and profitability of the company's core business operations.
help

How much debt does Inogen (INGN) have?

Inogen (INGN) has a total debt of $19.41M. The net debt, which accounts for cash and cash equivalents against the total debt, is -$85.54M.

Take Your Investments to a Whole New Level